Jan 30, 2016 - Bay Area by Ingrid Evans | Share
ATTORNEY NEWSLETTER Endo Pharmceuticals and seven of its subsidiaries will pay $39 million to settle a whistleblower qui tam lawsuit alleging that the company manufactured and sold fluoride multivitamins containing less than half the labeled dosage. Fluoride is important to the dental health of children. Generally, we could find fluoride […]